On 5th December 2001, Phytopharm announced the successful completion of the third and final stage on their proof of principle, clinical study, of the molecule named P57. This press release states that P57, is patented by Phytopharm and is under development as an appetite suppressant for the treatment of obesity and related conditions.
The object of [...]
Phytopharm is the British pharmaceutical company, which has the patent rights to develop Hoodia products that contain pure Hoodia Gordonii. In other words, the Hoodia Gordonii product coming from Phytopharm, contains the correct level of the chemical constituent P57, which produces the effect of weight loss.
In Phytopharm’s website, the company states “Importantly, only Phytopharm’s Hoodia [...]
After the CSIR isolated the active ingredient, they licensed the patent rights for P-57 to Phytopharm, a British based pharmaceutical company. A lot of people think of Phizer hoodia (more commonly spelled Pfizer) because they think the well known pharmaceutical giant here in the United States had the patent rights to the active ingredient
Phytopharm is a leading company in the development of Botanical pharmaceuticals. Botanicals help to understand how plant medicines can be in used to treat chronic and diseases about which very littlie information is available. When such research shows substantially good results, they form the basis for drug discovery platforms. Such platforms enable the development of [...]
